A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn whether Saxagliptin added to
thiazolidinedione (TZD) therapy is more effective than TZD alone as a treatment for Type 2
diabetic subjects who are not sufficiently controlled with TZD alone